These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7886978)

  • 21. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB; Wedel MK; Xia S; Baker BF
    Aliment Pharmacol Ther; 2006 May; 23(10):1403-13. PubMed ID: 16669955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
    Kleykamp BA; Jennings JM; Sams C; Weaver MF; Eissenberg T
    Exp Clin Psychopharmacol; 2008 Apr; 16(2):99-112. PubMed ID: 18489014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
    van Deventer SJ; Wedel MK; Baker BF; Xia S; Chuang E; Miner PB
    Aliment Pharmacol Ther; 2006 May; 23(10):1415-25. PubMed ID: 16669956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis.
    Marakhouski Y; Fixa B; Holomán J; Hulek P; Lukas M; Bátovský M; Rumyantsev VG; Grigoryeva G; Stolte M; Vieth M; Greinwald R;
    Aliment Pharmacol Ther; 2005 Jan; 21(2):133-40. PubMed ID: 15679762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?].
    Folwaczny C
    Z Gastroenterol; 2000 Jun; 38(6):547-50. PubMed ID: 10923365
    [No Abstract]   [Full Text] [Related]  

  • 29. Twelve-week outcomes from an investigation of high-dose nicotine patch therapy for heavy smokers with a past history of alcohol dependence.
    Kalman D; Kahler CW; Tirch D; Kaschub C; Penk W; Monti PM
    Psychol Addict Behav; 2004 Mar; 18(1):78-82. PubMed ID: 15008689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subgroups of smokers with different success rates after use of transdermal nicotine.
    Swan GE; Jack LM; Ward MM
    Addiction; 1997 Feb; 92(2):207-17. PubMed ID: 9158232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotine fix.
    Mandavilli A
    Nat Med; 2004 Jul; 10(7):660-1. PubMed ID: 15229501
    [No Abstract]   [Full Text] [Related]  

  • 32. Review article: the management of steroid dependency in ulcerative colitis.
    Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S
    Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine-replacement products in smoking cessation: a review.
    Alsagoff F; Lee HP
    Singapore Med J; 1993 Dec; 34(6):505-10. PubMed ID: 8153711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma fibrinogen in ulcerative colitis: the effect of disease activity and nicotine therapy in a randomised controlled trial.
    Ingram JR; Rhodes J; Collins PW; Williams GT; Newcombe RG; Thomas GA
    Dig Liver Dis; 2005 Nov; 37(11):832-7. PubMed ID: 16169302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of the active moiety of BX661A, a new therapeutic agent for ulcerative colitis, by studying its therapeutic effects on ulcerative colitis induced by dextran sulfate sodium in rats.
    Kimura I; Kawasaki M; Nagahama S; Matsuda A; Kataoka M; Kokuba Y
    Arzneimittelforschung; 1998 Nov; 48(11):1091-6. PubMed ID: 9850431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostaglandins and ulcerative colitis.
    Gilat T; Ratan J; Rosen P; Peled Y
    Gastroenterology; 1979 May; 76(5 Pt 1):1083. PubMed ID: 374175
    [No Abstract]   [Full Text] [Related]  

  • 37. Steroid-sparing effect of transdermal nicotine in ulcerative colitis.
    Guslandi M; Tittobello A
    J Clin Gastroenterol; 1994 Jun; 18(4):347-8. PubMed ID: 8071525
    [No Abstract]   [Full Text] [Related]  

  • 38. Nicotine treatment in ulcerative colitis. Current status.
    Rhodes J; Thomas G
    Drugs; 1995 Feb; 49(2):157-60. PubMed ID: 7729324
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recommendation of a new therapeutic method in ulcerative colitis (author's transl)].
    Gibiński K
    Cesk Gastroenterol Vyz; 1973 Oct; 27(7):480-2. PubMed ID: 4543372
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of nicotine patches in patients with coronary artery disease: are they safe?
    Drown DJ
    Prog Cardiovasc Nurs; 1994; 9(4):42. PubMed ID: 7846005
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.